Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

A new study reveals that the popular diabetes and weight-loss drug Ozempic might hold the key to relieving chronic migraines, ...

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.

Migraine symptoms can last for hours or days, and they can be serious and debilitating; according to the World Health Organization (WHO), migraine is ranked the sixth most disabling disease, globally.

Expert Rev Clin Pharmacol. 2013;6(3):271-288. All FDA-approved migraine treatments are approved only for adults. No migraine products have officially been approved for use in children. Other types ...

Treatment Consideration in Special Populations Migraine & Pregnancy Studies indicate a decreased frequency of headache activity (57%) in the first trimester and 85% in the second/third trimester ...

AbbVie beat out a competitor's migraine-fighting drug in terms of dose tolerability in a head-to-head study. The North Chicago-based drugmaker said its Phase 3 study of atogepant (Qulipta) in a ...

Objective Accumulating evidence has supported the association between migraine and stroke, but the causative association remains unclear. We aimed to investigate the risks of different types of stroke ...

Migraine continues to be underdiagnosed and undertreated, despite significant burden on patients' lives. 2 It is a complex neurological disease that affects approximately 14% of the global ...

Migraine most frequently causes simple visual hallucinations, but complex visual hallucinations may occur in basilar migraine and familial hemiplegic migraine. In contrast to hallucinations in ...